What are the targeted drugs for treating small cell lung cancer? Learn about these

Now people's living standards are getting better and better, medical technology is getting more powerful, and there are many drugs for treating small cell lung cancer. For example, the usage rate of targeted drugs such as osimertinib, afatinib, Tarceva, and gefitinib is very high, and the effects they can achieve are also very good. You can choose according to your actual physical condition.

After cancer occurs in the body, the correct treatment method needs to be decided based on the degree of development and size of the cancer. Targeted drug therapy can be chosen. There are many types of targeted drugs. You can learn about the more common ones. Here I will introduce to you what are the targeted drugs for treating small cell lung cancer?
Osimertinib is a relatively common, third-generation targeted drug. If small cell lung cancer has reached an advanced stage, the effect of this drug treatment is very obvious. It has strong drug resistance and the effect of long-term use is also very good. You can also use afatinib, which is a second-generation targeted drug and an inhibitor. It has a good inhibitory effect on the mutation of cancer cells. If cancer cells mutate, this drug treatment is the most suitable.
Tarceva can also be used. When chemotherapy does not achieve good results after the onset of small cell lung cancer, Tarceva will be more effective at this time as it is more sensitive to cancer cells. Gefitinib can also be used. After the onset of small cell lung cancer, if it has reached the late stage and has metastasized or spread, this drug treatment has a very good effect and can effectively control the disease and improve the patient's quality of life.
Imatinib is also a type of targeted drug. If the effects of combined chemotherapy and drug treatment are very unobvious, and mutations have occurred in gastrointestinal stromal tumors, the use of this targeted drug has a good effect, can improve the patient's physical symptoms, and also make the patient feel much more comfortable.
Another targeted drug for the treatment of small cell lung cancer is pazopanib, which is a multi-target inhibitor that can resist a variety of tumors and has a good therapeutic effect on soft tissue sarcoma and renal cell carcinoma. It is closely related to metastasis and tumor proliferation.
The above introduces what targeted drugs are there for the treatment of small cell lung cancer. Through the above introduction, everyone should know that if you want to treat small cell lung cancer well, it is important to choose the right treatment method. Targeted therapy is a very good one, which can achieve good results in improving the disease, make the uncomfortable problems disappear as soon as possible, and improve the patient's quality of life.